Alan Walker

Significant transactions, both prior to and since joining Kirkland, include advising:

• BC Partners on the acquisition of a majority stake in PetLab Co
• TDR-backed Hurtigruten to complete a recapitalization transaction
• Inspired Pet Nutrition, a portfolio company of CapVest, on its acquisition of Butcher’s Pet Care
• Apax on the acquisition of Zellis
• Bain Capital on the acquisition of a controlling stake in Eleda
• Apax on the acquisitions of OCS and Finwave
• Apax Partners LLP on the unitranche financing for the acquisition of WGSN Limited from Ascential plc.
• Apax Partners and Healthium on the sale of Clinisupplies
• Bain Capital Private Equity on the €955.3 million public takeover of Caverion Corporation
• Technicolor on the spinoff and listing of its creative visual arts services division
• Bain Capital Private Equity on the €3 billion acquisition and financing for Fedrigoni
• Apax Partners on Recommended Cash Offer for EcoOnline Holding AS 
• Bain Capital on the sale of Geometric Results, Inc. to PRO Unlimited 
• Citigroup on the £115 million IPO on the London Stock Exchange of Hiro Metaverse Acquisitions I S.A., a special purpose acquisition company 
• BC Partners on the sale of UK based mental healthcare provider Elysium Healthcare to Ramsay Health Care
• Davies Group, a portfolio company of BC Partners, on the acquisition of global consulting firm Sionic Group from Livingbridge and management
• Inmarsat and its controlling consortium on the $7.3 billion combination with Viasat, Inc.
• Davies Group, a portfolio company of BC Partners, on the strategic acquisition of Asta, a leading third party managing agent at Lloyd’s
• BC Partners on the sale of European pharmaceutical company Pharmathen to Partners Group 
• BC Partners on the acquisition of a significant stake in Valtech, a global digital services and business transformation agency
• AJAX I on its $7 billion business combination agreement with Cazoo Holdings Limited
• Funds advised by Apax on the definitive agreement to acquire a majority stake in Lutech SpA, a leading Italian IT services, software and technology company 
• ABRY Partners on its investment in the $350 million capital raise by ERS 
• L Catterton on its agreement to acquire a majority stake in BIRKENSTOCK Group
• Funds managed by Apax Partners on the acquisition of the PIB Group, a leading independent specialist insurance intermediary
• Presidio, a portfolio company of BC Partners, on its acquisition of Arkphire, a leading IT product procurement and services company
• BC Partners on its acquisition of Keesing, a leading European braintainment business, from Ergon Capital and Mediahuis 
• CapVest Partners on the acquisition of Datasite Global Corporation, a leading Software-as-a-Service provider
• Advanced, a portfolio company of BC Partners and Vista Equity Partners, on the acquisition of Mitrefinch from LDC
• Tokio Marine HCC in relation to its acquisition of GCube
• Hospital Topco, majority owned by Centerbridge and KKR, on the c.£1.8 billion disposal of BMI Healthcare and the GHG Group
• the administrators in relation to the UK administration of Mothercare
• STADA on the $660 million acquisition of a portfolio of over-the-counter and prescription pharmaceutical assets in Russia, Georgia and the CIS from Takeda
• The adhoc committee of convertible bondholders in relation to the €2.6 debt restructuring of Steinhoff
• a consortium consisting of Apax, Warburg Pincus, Canada Pension Plan Investment Board and Ontario Teachers’ Pension Plan in relation to the $3.4 billion take private of Inmarsat
• Centerbridge and KKR in relation to the c.£2.5 billion debt restructuring of General Healthcare Group and its acquisition of BMI Healthcare
• ABRY Partners in relation to their preferred equity investment in Sermo
• Alvarez & Marsal Capital in relation to the structuring of its first European buyout fund and establishment of its UK investment advisory business
• Global Logisitics Properties, in relation to its USD 2.8 billion acquisition of Gazeley
• Toys ‘R’ Us in relation to its UK administration and the disposal of its European business and restructuring of its Asian business
• Deutsche Börse in relation to its proposed merger with the London Stock Exchange
• Novartis in relation to the £5.5 billion sale of its vaccines business to Glaxosmithkline
• Cinven in relation to the raising of its fifth and sixth buyout funds
• the majority of the UK’s major privately owned water and sewerage groups in relation to their £ multi-billion secured debt financing platforms

Linklaters LLP, London, UK

• Counsel, 2017–2018

• Managing Associate, 2009–2017

• Associate, 2004–2008

• Trainee Solicitor, 2002–2004